Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 2,380,000 shares, an increase of 33.7% from the March 15th total of 1,780,000 shares. Based on an average daily trading volume, of 1,130,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 4.1% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on HYPR shares. B. Riley reduced their target price on shares of Hyperfine from $1.50 to $1.20 and set a “buy” rating for the company in a report on Thursday, March 20th. Wells Fargo & Company boosted their price target on Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th. Finally, Lake Street Capital initiated coverage on shares of Hyperfine in a research report on Monday, March 24th. They set a “buy” rating and a $1.50 price objective on the stock.
View Our Latest Analysis on HYPR
Hedge Funds Weigh In On Hyperfine
Hyperfine Trading Up 4.1 %
Shares of HYPR stock opened at $0.70 on Monday. The stock has a market capitalization of $54.18 million, a price-to-earnings ratio of -1.22 and a beta of 1.05. Hyperfine has a 12-month low of $0.58 and a 12-month high of $1.90. The stock’s 50-day moving average price is $0.87 and its 200-day moving average price is $0.96.
Hyperfine (NASDAQ:HYPR – Get Free Report) last posted its earnings results on Monday, March 17th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The firm had revenue of $2.32 million during the quarter, compared to the consensus estimate of $2.30 million. During the same period in the prior year, the company earned ($0.15) EPS. As a group, research analysts predict that Hyperfine will post -0.57 EPS for the current fiscal year.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Further Reading
- Five stocks we like better than Hyperfine
- Why is the Ex-Dividend Date Significant to Investors?
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- The Risks of Owning Bonds
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- 3 Fintech Stocks With Good 2021 Prospects
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.